New stem cell method aims to fight blood cancers with fewer side effects
NCT ID NCT02323867
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 24 times
Summary
This study tests a special stem cell transplant for people with blood cancers like leukemia and lymphoma. Doctors use donor stem cells that have been filtered to remove certain immune cells, which may help the body accept the transplant and reduce harmful side effects like graft-versus-host disease. The goal is to see if this approach leads to successful engraftment and better survival after one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19103, United States
Conditions
Explore the condition pages connected to this study.